• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫检查点抑制剂时代的循环和肿瘤相关中性粒细胞:动态变化、表型、代谢及功能

Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions.

作者信息

Gibellini Lara, Borella Rebecca, Santacroce Elena, Serattini Eugenia, Boraldi Federica, Quaglino Daniela, Aramini Beatrice, De Biasi Sara, Cossarizza Andrea

机构信息

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, 41121 Modena, Italy.

Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

出版信息

Cancers (Basel). 2023 Jun 24;15(13):3327. doi: 10.3390/cancers15133327.

DOI:10.3390/cancers15133327
PMID:37444436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10341361/
Abstract

Neutrophils are the most abundant myeloid cells in the blood and are a considerable immunological component of the tumor microenvironment. However, their functional importance has often been ignored, as they have always been considered a mono-dimensional population of terminally differentiated, short-living cells. During the last decade, the use of cutting-edge, single-cell technologies has revolutionized the classical view of these cells, unmasking their phenotypic and functional heterogeneity. In this review, we summarize the emerging concepts in the field of neutrophils in cancer, by reviewing the recent literature on the heterogeneity of both circulating neutrophils and tumor-associated neutrophils, as well as their possible significance in tumor prognosis and resistance to immune checkpoint inhibitors.

摘要

中性粒细胞是血液中最丰富的髓样细胞,是肿瘤微环境中相当重要的免疫组成部分。然而,它们的功能重要性常常被忽视,因为它们一直被认为是终末分化、寿命短暂的单一类型细胞群体。在过去十年中,前沿的单细胞技术的应用彻底改变了对这些细胞的传统看法,揭示了它们的表型和功能异质性。在这篇综述中,我们通过回顾关于循环中性粒细胞和肿瘤相关中性粒细胞异质性的最新文献,以及它们在肿瘤预后和对免疫检查点抑制剂耐药性方面的可能意义,总结了癌症领域中性粒细胞的新出现的概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a96/10341361/2fb2b621c16e/cancers-15-03327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a96/10341361/9d120f80b4e0/cancers-15-03327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a96/10341361/c2b88c55fae4/cancers-15-03327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a96/10341361/2fb2b621c16e/cancers-15-03327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a96/10341361/9d120f80b4e0/cancers-15-03327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a96/10341361/c2b88c55fae4/cancers-15-03327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a96/10341361/2fb2b621c16e/cancers-15-03327-g003.jpg

相似文献

1
Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions.免疫检查点抑制剂时代的循环和肿瘤相关中性粒细胞:动态变化、表型、代谢及功能
Cancers (Basel). 2023 Jun 24;15(13):3327. doi: 10.3390/cancers15133327.
2
Neutrophils in cancer: heterogeneous and multifaceted.癌症中的中性粒细胞:异质性与多面性。
Nat Rev Immunol. 2022 Mar;22(3):173-187. doi: 10.1038/s41577-021-00571-6. Epub 2021 Jul 6.
3
Neutrophils in the era of immune checkpoint blockade.免疫检查点阻断时代的中性粒细胞。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2020-002242.
4
The dual role of neutrophils in cancer.中性粒细胞在癌症中的双重作用。
Semin Immunol. 2021 Oct;57:101582. doi: 10.1016/j.smim.2021.101582. Epub 2021 Dec 30.
5
Versatile neutrophil functions in cancer.中性粒细胞在癌症中的多功能作用。
Semin Immunol. 2021 Oct;57:101538. doi: 10.1016/j.smim.2021.101538. Epub 2021 Dec 4.
6
Myeloid cell heterogeneity in cancer: not a single cell alike.癌症中的髓系细胞异质性:没有两个细胞是完全相同的。
Cell Immunol. 2018 Aug;330:188-201. doi: 10.1016/j.cellimm.2018.02.008. Epub 2018 Feb 14.
7
Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression.肿瘤相关中性粒细胞在癌症发展和进展中的双面角色。
Int J Mol Sci. 2020 May 14;21(10):3457. doi: 10.3390/ijms21103457.
8
Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies.中性粒细胞在癌症中的多样化功能和有前景的基于中性粒细胞的癌症治疗方法。
Int J Mol Sci. 2022 Dec 13;23(24):15827. doi: 10.3390/ijms232415827.
9
Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance.肿瘤相关中性粒细胞:调控癌症病理生物学和治疗抵抗。
Expert Opin Ther Targets. 2021 Jul;25(7):573-583. doi: 10.1080/14728222.2021.1954162. Epub 2021 Jul 16.
10
Tumor-associated neutrophils and neutrophil-targeted cancer therapies.肿瘤相关中性粒细胞与针对中性粒细胞的癌症治疗
Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188762. doi: 10.1016/j.bbcan.2022.188762. Epub 2022 Jul 16.

引用本文的文献

1
Tumor-associated neutrophils in breast cancer: an angel or a devil?乳腺癌中的肿瘤相关中性粒细胞:天使还是魔鬼?
Front Immunol. 2025 Jun 11;16:1593156. doi: 10.3389/fimmu.2025.1593156. eCollection 2025.
2
Tumor-associated neutrophils and neutrophil extracellular traps in lung cancer: antitumor/protumor insights and therapeutic implications.肺癌中的肿瘤相关中性粒细胞与中性粒细胞胞外诱捕网:抗肿瘤/促肿瘤见解及治疗意义
Med Oncol. 2025 Jun 16;42(7):266. doi: 10.1007/s12032-025-02831-0.
3
Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial.

本文引用的文献

1
VISTA expression and patient selection for immune-based anticancer therapy.VISTA 表达与基于免疫的抗肿瘤治疗的患者选择。
Front Immunol. 2023 Feb 20;14:1086102. doi: 10.3389/fimmu.2023.1086102. eCollection 2023.
2
Heterogeneity of neutrophils in cancer: one size does not fit all.中性粒细胞在癌症中的异质性:一刀切并不适用。
Cancer Biol Med. 2022 Dec 12;19(12):1629-48. doi: 10.20892/j.issn.2095-3941.2022.0426.
3
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer.
补充二十二碳六烯酸(DHA)可减轻接受新辅助治疗的乳腺癌患者外周血免疫细胞在浓度、表型及反应方面的变化。DHA-WIN试验的次要研究结果。
Breast Cancer Res. 2025 May 22;27(1):91. doi: 10.1186/s13058-025-02048-z.
4
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies.实体瘤中的免疫调节与免疫治疗:耐药机制及潜在治疗策略
Int J Mol Sci. 2025 Mar 24;26(7):2923. doi: 10.3390/ijms26072923.
5
Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections.探索疾病中的糖酵解酶:神经退行性疾病、癌症和寄生虫感染中的潜在生物标志物及治疗靶点
Open Biol. 2025 Feb;15(2):240239. doi: 10.1098/rsob.240239. Epub 2025 Feb 5.
6
Prognostic roles of hematological indicators in programmed cell death protein 1/programmed cell death ligand 1 inhibitors for small-cell lung cancer: a retrospective cohort study.血液学指标在程序性细胞死亡蛋白1/程序性细胞死亡配体1抑制剂治疗小细胞肺癌中的预后作用:一项回顾性队列研究
J Thorac Dis. 2024 Dec 31;16(12):8669-8683. doi: 10.21037/jtd-24-1826. Epub 2024 Dec 28.
7
Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment.阻断胰腺导管腺癌中癌症相关成纤维细胞上的IL1RAP可抑制IL-1诱导的中性粒细胞募集。
J Immunother Cancer. 2024 Dec 18;12(12):e009523. doi: 10.1136/jitc-2024-009523.
8
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.去分化过程驱动的表观遗传改变中肺癌干细胞的分子特征。
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
9
Neutrophil estimation and prognosis analysis based on existing lung squamous cell carcinoma datasets: the development and validation of a prognosis prediction model.基于现有肺鳞状细胞癌数据集的中性粒细胞评估与预后分析:一种预后预测模型的开发与验证
Transl Lung Cancer Res. 2024 Aug 31;13(8):2023-2037. doi: 10.21037/tlcr-24-411. Epub 2024 Aug 19.
10
Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers.抗白细胞介素-8 抑制剂 AMY109 联合阿特珠单抗治疗晚期实体瘤患者的安全性和临床活性的 I 期研究。
J Immunother Cancer. 2024 Jul 24;12(7):e009262. doi: 10.1136/jitc-2024-009262.
高分辨率单细胞图谱揭示了非小细胞肺癌中组织驻留中性粒细胞的多样性和可塑性。
Cancer Cell. 2022 Dec 12;40(12):1503-1520.e8. doi: 10.1016/j.ccell.2022.10.008. Epub 2022 Nov 10.
4
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.肝肿瘤免疫微环境亚型与中性粒细胞异质性
Nature. 2022 Dec;612(7938):141-147. doi: 10.1038/s41586-022-05400-x. Epub 2022 Nov 9.
5
Established and emerging roles for mitochondria in neutrophils.线粒体在中性粒细胞中的既定和新兴作用。
Immunol Rev. 2023 Mar;314(1):413-426. doi: 10.1111/imr.13158. Epub 2022 Nov 4.
6
Single-cell transcriptome profiling reveals heterogeneous neutrophils with prognostic values in sepsis.单细胞转录组分析揭示脓毒症中具有预后价值的异质性中性粒细胞。
iScience. 2022 Oct 7;25(11):105301. doi: 10.1016/j.isci.2022.105301. eCollection 2022 Nov 18.
7
Neutrophil extracellular traps: New players in cancer research.中性粒细胞胞外陷阱:癌症研究的新角色。
Front Immunol. 2022 Aug 19;13:937565. doi: 10.3389/fimmu.2022.937565. eCollection 2022.
8
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer.靶向谷氨酰胺代谢增强表皮生长因子受体驱动的肺癌免疫预防。
Adv Sci (Weinh). 2022 Sep;9(26):e2105885. doi: 10.1002/advs.202105885. Epub 2022 Jul 21.
9
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia.老年重症 COVID-19 肺炎患者的分子和细胞免疫特征。
Commun Biol. 2022 Jun 16;5(1):590. doi: 10.1038/s42003-022-03537-z.
10
Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.单细胞 RNA 测序分析揭示了胰腺肿瘤微环境中 BHLHE40 驱动的促肿瘤嗜中性粒细胞,其糖酵解活性增强。
Gut. 2023 May;72(5):958-971. doi: 10.1136/gutjnl-2021-326070. Epub 2022 Jun 10.